BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5347413)

  • 1. Brocresine, a histidine decarboxylase inhibitor, in chronic urticaria.
    Zachariae H; Brodthagen H; Sondergaard J
    J Invest Dermatol; 1969 Nov; 53(5):341-3. PubMed ID: 5347413
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of brocresine (NSD 1055)--a histidine decarboxylase inhibitor--to influence skin histamine in mice.
    Zachariae H; Sondergaard J; Husseini R; Carlsen R
    Acta Allergol; 1970 Jun; 25(2):216-20. PubMed ID: 5536091
    [No Abstract]   [Full Text] [Related]  

  • 3. Histamine excretion and dermographism in urticaria pigmentosa before and after administration of a specific histidine-decarboxylase inhibitor.
    Greaves MW
    Br J Dermatol; 1971 Nov; 85(5):467-70. PubMed ID: 4108905
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the histidine decarboxylase inhibitor brocresine (NSD-1055) on gastric histidine decarboxylase and hydrochloric acid secretion in rats].
    Mesch H; Becker M; Sewing KF
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):402-3. PubMed ID: 4253829
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of brocresine (NSD-1055) on basal and stimulated gastric acid secretion in chickens.
    Krämer B; Ruoff HJ; Sewing KF
    Arzneimittelforschung; 1975 Nov; 25(11):1800-2. PubMed ID: 1243089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibition of histidine decarboxylase on implantation in the mouse.
    Cox C; Mukerjee S; Jackson M; Dey SK
    Contraception; 1981 Apr; 23(4):457-61. PubMed ID: 6895060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic urticaria with ketotifen].
    Guillot B; Meynadier J
    Allerg Immunol (Paris); 1986 Sep; 18(7):33-5. PubMed ID: 2899435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histamine therapy in the complex treatment of chronic urticaria].
    Vasil'eva TG
    Klin Med (Mosk); 1986 Nov; 64(11):119-22. PubMed ID: 3821023
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperchlorhydria and hyperhistaminemia in a patient with systemic mastocytosis.
    Keller RT; Roth HP
    N Engl J Med; 1970 Dec; 283(26):1449-50. PubMed ID: 5481779
    [No Abstract]   [Full Text] [Related]  

  • 10. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
    Sanada S; Tanaka T; Kameyoshi Y; Hide M
    Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of treatment with loratadine in patients with chronic urticaria].
    Siergiejko Z; Chyrek-Borowska S
    Pol Tyg Lek; 1994 Apr 4-11; 49(14-15):334-6. PubMed ID: 7854994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic urticaria. Treatment with ketotifen].
    Camarasa JG; Moragas JM
    Med Cutan Ibero Lat Am; 1982; 10(5):339-42. PubMed ID: 6764233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of systemic corticosteroids on cutaneous histamine secretion and histamine-releasing factor in patients with chronic idiopathic urticaria.
    Paradis L; Lavoie A; Brunet C; Bédard PM; Hébert J
    Clin Exp Allergy; 1996 Jul; 26(7):815-20. PubMed ID: 8842556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Self assessment of the effect of antihistaminics by patients with chronic recurring urticaria].
    Ziegler B; Haustein UF
    Dermatol Monatsschr; 1986; 172(3):163-7. PubMed ID: 3699212
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic urticaria with a new synthetic antihistamine: astemizole].
    Annunziata M; Aimo Boot D
    G Ital Dermatol Venereol; 1984; 119(5):XVII-XX. PubMed ID: 6150894
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay and rapid disappearnace of brocresine activity in blood.
    Ellenbogen L; Stubbs CS; Markley E; Taylor RJ
    Biochem Pharmacol; 1971 Jul; 20(7):1501-6. PubMed ID: 5126487
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined H1 and H2 antihistamine therapy in chronic urticaria.
    Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
    Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxatomide in the treatment of chronic urticaria: evaluation of its effectiveness and tolerance].
    Pigatto PD; Nicora M; Altomare GF; Morelli M; Finzi AF
    G Ital Dermatol Venereol; 1987 May; 122(5):XXV-XXIX. PubMed ID: 2887510
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue fluid histamine levels in chronic urticaria.
    Fine RM
    Int J Dermatol; 1978 Dec; 17(10):792. PubMed ID: 730433
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of histamine-releasing factor recovered from skin and peripheral blood mononuclear cells of patients with chronic idiopathic urticaria.
    Claveau J; Lavoie A; Brunet C; Bédard PM; Hébert J
    Ann Allergy Asthma Immunol; 1996 Dec; 77(6):475-9. PubMed ID: 8970437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.